F630-1023 Screening compound: 5-(5-cyclobutyl-1,3,4-oxadiazol-2-yl)-N-[3-(1,2-oxazol-5-yl)phenyl]thiophene-2-sulfonamide

F630-1023 Screening compound: 5-(5-cyclobutyl-1,3,4-oxadiazol-2-yl)-N-[3-(1,2-oxazol-5-yl)phenyl]thiophene-2-sulfonamide
F630-1023 Screening compound: 5-(5-cyclobutyl-1,3,4-oxadiazol-2-yl)-N-[3-(1,2-oxazol-5-yl)phenyl]thiophene-2-sulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F630-1023
5-(5-cyclobutyl-1,3,4-oxadiazol-2-yl)-N-[3-(1,2-oxazol-5-yl)phenyl]thiophene-2-sulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F630-1023

Molecular Formula

C19H16N4O4S2 (C19 H16 N4 O4 S2)

Compound Name

5-(5-cyclobutyl-1,3,4-oxadiazol-2-yl)-N-[3-(1,2-oxazol-5-yl)phenyl]thiophene-2-sulfonamide

IUPAC name

5-(5-cyclobutyl-134-oxadiazol-2-yl)-N-[3-(12-oxazol-5-yl)phenyl]thiophene-2-sulfonamide

SMILES

O=S(c1ccc(-c2nnc(C3CCC3)o2)s1)(Nc1cc(-c2ccno2)ccc1)=O

InChI

InChI=1S/C19H16N4O4S2/c24-29(25,23-14-6-2-5-13(11-14)15-9-10-20-27-15)17-8-7-16(28-17)19-22-21-18(26-19)12-3-1-4-12/h2,5-12,23H,1,3-4H2

InChI Key

DNZAPQIZHDQQOG-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27180329

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

428.49

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.579

Distribution Coefficient, logD

3.578

Water Solubility, LogSw

-3.69

Polar Surface Area

94.543

Acid Dissociation Constant (pKa)

10.72

Base Dissociation Constant (pKb)

-0.51

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

21.10

F630-1023 in Drug Discovery

Included in Screening Libraries

Angiogenesis library (14822 compounds)

KRAS-Targeted Library (16000 compounds)

Nonpeptide Peptidomimetics PPI Library (18997 compounds)

Protein-Protein Interaction Library (218420 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with F630-1023 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F630-1023?
Check Price and Availability of F630-1023, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F630-1023 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F630-1023
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F630-1023
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F630-1023 available by request